Новости

COBATEST Netork is pleased to anounce some important updates regarding the official documents that will be in use from January 1 onwards.

1. New Data Collection Form and Instructions:

   We are pleased to share with you the updated data collection form along with comprehensive instructions for its completion. 

2. Data Collection Forms for PrEP/Chemsex Modules and Other STIs:

   In addition to the general data collection form, we have included the specific updated forms for PrEP/Chemsex modules and other sexually transmitted infections, for those who collect this data.

3. Instructions and Aggregated Data Excel:

   For those submitting aggregated data, detailed instructions and an Excel sheet for aggregated data reporting have been updated.

4. Instructions and Disaggregated Data Excel:

   Likewise, for those submitting disaggregated data, please find updated instructions and the corresponding Excel sheet for your reporting.

All updated documents can be foun in здесь.

The HepHIV 2023 conference took place from November 13th to 15th, 2023 in Madrid, Spain. Results from three research studies were presented by COBATEST network at the conference.

Dr. Megi Gogishvili presented findings of a study on HIV positive diagnosis among migrants compared to native-born in Europe and Central Asia. 

Presentation demonstrated analysis of HIV-testing trends and prevalence of HIV positive diagnosis among migrants in Europe and Central Asia (ECA) compared with native-born individuals in 2021 and 2022. All 62 CBVCTs from COBATEST network who submitted standardized aggregated or disaggregated data in both years were included in the study. As conclusions, we found that migrants in ECA had a higher risk of HIV-positive diagnoses compared to native-born individuals in both years, with increased prevalence ratio in 2022 compared to 2021. We also identified transgender migrants, MSM migrants, and MSM native-born, at higher risk of HIV-positive diagnoses compared with non-MSM, and other sex in case of transgender migrants. Further research performing analysis by migrants’ country of origin and including data from 2023 is needed to assess whether the influx of migrants from Ukraine is straining available HIV-related resources and impacting the health of newly arrived PLHIV. This analysis is of crucial importance and is need to inform future interventions to further guarantee access to HIV care and treatment to all migrants. Please find the full results in the presentation онлайн.

Dr. Miguel Alarcón Gutiérrez presented findings of a study on Chemsex, HIV testing and associated factors in gay, bisexual and other men who have sex with men (GBMSM) and transgender individuals, among European community-based centres.

A presentation consisted of analysis of associated factors with chemsex practice among GBMSM and transgender population who attended community-based voluntary counselling and HIV/STI testing (CBVCT) centres in Europe. We included 31 COBATEST Network CBVCT centres from Belgium, Italy and Spain who submitted chemsex-related questions, between 2019 and 2022. After analysis, we concluded that chemsex is a prevalent practice among GBMSM and transgender people who attend CBVCT centres and it is significantly related to HIV positive testing. Vulnerable subpopulations and specific opportunities were identified to generate interventions oriented to the prevention of chemsex related harms in the CBVCT setting. Please find the full results in the presentation онлайн. 

Dr. Laura Fernández López presented a poster with the findings of a study on the assessment of HIV self-testing and self-sampling use and intention to use among COBATEST Network members. 

The poster consisted of the analysis of the use of HIV self-testing (HST) and self-sampling (HSS) among COBATEST Network members as part of the project ‘Community Led and Based HIV Services-Key to Ending the HIV Epidemic in Europe and Central Asia “Zeroing In-Ending the HIV Epidemic”‘. An online survey was conducted among COBATEST network members from February to March 2023, covering different aspects related to the use or intention to use of HST/HSS in their services. HSS was less utilized than HST among COBATEST Network members. Legal considerations posed barriers to both methods, and primary reasons for not offering them were concerns about price, follow-up, linkage to care, and concerns about self-administration without counselling. Despite high client interest, ensuring effective follow-up of test results remained a significant challenge. Please find the full results in the poster онлайн.

The XLI Spanish Epidemiology Society (SEE) meeting took place from September 5th to 8th, 2023 in Porto, Portugal. Two abstracts were presented by COBATEST network at the meeting.

Dr. Megi Gogishvili presented an abstract on the impact of COVID-19 on HIV-testing among community centers in Catalonia. 

Presentation consisted of time series analysis of the testing trends from 2018 to 2020. Four periods were analysed: pre-lockdown (PRE), lockdown (LD), de-escalation (DE), and new normality (NN). In total, 18,265 tests were reported. Males comprised 56.1% of testers in PRE, 71.4% in LD and 49.5% in NN, while largest proportion of females were found in DE (54.1%). During PRE 10,034 tests were performed, during LD 82 (84.4% less than expected), 211 during DE (62.5% less), and 2305 in NN, which is 12.5% less than predicted by the model according to the previous trends. Males had the highest difference in expected to observed tests (LD = 86.3%, DE = 73.9% and NN = 24.3% less than expected). Females tested 81.1% (LD) and 37.5% (DE) less than expected and 2.9% more than expected during NN. Transgenders tested 86.7% less than expected in LD, 92.9% in DE, and 25.2% in NN. Meno who have sex with men (MSM) tested 87.9% less than expected during LD, 84.8% during DE, and 34.5% during NN. Sex workers (SWs) tested 86.5%, 83.1%, and 33.8% less than expected. People who inject drugs (PWIDs) tested 62.5%, 46.2%, and 33.3% less than expected. Migrants tested 84.9%, 51.1% less than expected and 10.4% more during NN. Please find full presentation онлайн.

Dr. Miguel Alarcón Gutiérrez presented an abstract based on analysis of quantitative data collected by COBATEST network members from 2013 to 2022 concentrating on transgender individuals and men who have sex with men (MSM).

A presentation consisted of analysis of HIV and other STI associated factors among MSM and transgender individuals in 60 European community-led testing centers from COBATEST network. Out of 81,776 testers were GBMSM and 1,603 were transgender individuals. Total reactive testing prevalence among GBMSM population was 5.89% (CI: 5.64-6.14), and 12.48% (CI: 10.90-14.19) among transgender individuals. Multivariate analysis in GBMSM showed that factors associated with reactive testing were: age (aOR=1.01; CI: 1.00-1.01), being a migrant from outside of European Union (EU) (aOR=1.77; CI: 1.56-2.00), have been previously tested for HIV (aOR=1.37; CI: 1.19-1.59), having any risk exposure as motivation for testing (aOR=1.64; CI: 1.46-1.85), condomless penetration during last sexual intercourse (aOR =1.34; CI: 1.21-1.49), previous STIs (aOR=2.04; CI: 1.78-2.33), and receiving money or drugs for sex during last 12 months (aOR=1.61; CI: 1.35-1.93). In transgender population, factors associated with reactive testing were being a migrant from outside of the EU (aOR=2.90; CI: 1.55-5.42), having any risk exposure as motivation for testing (aOR=1.95; CI: 1.39-2.74), previous STIs (aOR=1.60; CI: 1.07-2.39), and receiving money or drugs for sex during last 12 months (aOR=2.04; CI: 1.10-3.77). Please find full presentation онлайн. 

There are currently 2 vacancies in the COBATEST Steering Committee for the 3-year term 2024 – 2026, starting on 1st Jan 2024. One of the seats is reserved for a representative of Eastern Europe and Central Asia.

In accordance with the COBATEST Election Procedure и COBATEST Steering Committee Terms of Reference, the Steering Committee members are directly elected by the COBATEST members. This procedure ensures transparency and fair participation of the network’s members in the decision-making.

Всем членам сети настоятельно рекомендуется отправить свои кандидатуры (с 20 сентября по 17 октября), чтобы стать новыми членами Руководящего комитета и, конечно же, голосовать во время выборов (с 11 ноября по 25 ноября). Вы можете найти критерии приемлемости и другие подробности о выборах в документе «Объявление о выборах». Активное участие членов является очень важной частью формирования успешной сети! 

The AidsImpact conference took place from June 12th to 15th, 2023 in Stockholm, Sweden. Two abstracts were presented by COBATEST network at the conference.

Dr.Megi Gogishvili presented an abstract based on the quantitative and qualitative data collected through an online questionnaire from EECA members of COBATEST network, ECOM, AFEW, and Aids Action Europe in 2022. 

A presentation was conducted on the results of an assessment of operational and structural realities and obstacles encountered by CBVCTs in EECA during HIV/STI testing and data collection. The data was based on the assessment of 20 CBVCTS, 8 from Eastern European countries and 3 from Central Asian countries. Majority of CBVCTs (14/20) depended primary on international grants and only few (2/20) operated mainly on a local governmental funds. Target testing population of majority of the CBVCTs were MSM (15/20), PWIDs (13/20), and SW (12/20). While 13 of CBVCTs provided assistance on how to navigate national health systems, only 1 provided legal counselling. All CBVCTs tested for HIV, 17 of them on HCV, 13 on HBV, and only 3 on Syphilis. Only 5 CBVCTs could perform confirmatory tests in their centers. Fifteen CBVCTs provided self-testing kits, however only 2 always received results of the testing. All participating CBVCTs collected data, 14/20 utilized both online and offline tool. Data is mostly collected for donor reporting purposes. However, interest was shown in being able to utilize collected data for improving services provided, informing future projects, and publishing articles. Primary themes identified in challenges named while testing and collecting data were: lack of funding (for personnel, tests), confidentiality and stigma, and political environment of the countries (restrictive laws, war). Please find full presentation онлайн.

Dr.Laura Fernandez Lopez presented an abstract based on quantitative data collected by COBATEST network members from 2013 to 2022.

A presentation was conducted on a key population belonging and HIV associated factors among 60 European community-led testing centers from COBATEST network. 73,799 HIV tested people were included in the cross-sectional study, of whom 65.3% (n=48,168) belonged to some key population. HIV reactive testing general prevalence was 1.68% (CI:1.59-1.78), while in key population was 2.41% (CI:2.27-2.55) and 0.31% (CI:0.25-0.38) in non-key population. In the multivariate analysis in key population group, being younger (aOR=0.99; CI:0.986-0.999), a man (aOR=6.05; CI:4.44-8.24) or a transgender (aOR=10.02; CI:7.07-14.20), being migrant from abroad the UE (aOR=1.76; CI:1.52-2.04), less condomless penetration during last sexual intercourse (aOR=1.36; CI:1.19-1.55), previous STI during last 12 months (aOR=1.41; CI:1.17-1.71) and doing sexual work (aOR=1.56; CI:1.27-1.91) were significantly associated with HIV reactive testing. In contrast, in non-key population, associated factors to HIV reactive testing were being older (aOR=1.03; CI:1.02-1.05) and a man (aOR=1.93; CI:1.17-3.19). Please find full presentation онлайн. 

The biannual meeting of Steering Committee of the COBATEST Network was held on June 8^th and 9^th, 2023 in Berlin, Germany, on the campus of AIDS Action Europe. Great and productive discussions took place on updating data collection form, future planning for the network, and brainstorming for next COBATEST members annual meeting.

Сеть COBATEST принимает участие в проекте Boost 2023-2025, финансируемом за счёт гранта Европейской Комиссии, вместе с 45 участниками из более чем 20 организаций. Стартовая встреча проекта состоялась в Риме, Италия, 13 и 14 февраля 2023 года. В рамках проекта, COBATEST поможет улучшить сбор данных тестирования на ВИЧ/ВГС/ИППП среди служб снижения вреда по всей Европе.

Сеть COBATEST принимает участие в проекте CORE (Community Response to End Inequalities - Реакция сообщества на искоренение неравенства) на 2023-2025 годы, финансируемом за счёт гранта Европейской комиссии, вместе с участниками из более чем 20 организаций. Стартовая встреча проекта состоялась в Берлине, Германия, 30 января. COBATEST поможет общественным организациям улучшить мониторинг тестирования и связь с лечением ВИЧ/ИППП/ТБ/ВГ.

Сеть COBATEST приняла участие в EECA (ВЕЦА) Interact 2022, научном семинаре по ВИЧ, гепатиту С и туберкулёзу в Восточной Европе и Центральной Азии 13-14 декабря, 2022 года (Рига, Латвия).

Д-р Меги Гогишвили представила информацию о ходе сбора данных от членов COBATEST ВЕЦА. Данные показывают, что существует большой разрыв между тестированием на ВИЧ среди МСМ и других уязвимых групп в ВЕЦА, особенно среди трансгендеров, ЛУИН и СР. Низкий процент лиц, прошедших тестирование в течение последних 12 месяцев, и высокая доля положительных результатов тестирования указывают на необходимость расширения программ выездной проверки в странах ВЕЦА. В целом, в сети COBATEST было обнаружено увеличение участия членов ВЕЦА, но представление данных не является постоянным в течение 5 лет. Пожалуйста, найдите полную презентацию онлайн.